GNS Healthcare, Brigham & Women's Collaborate on Adverse Drug Events Prediction | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GNS Healthcare today said that it will collaborate with researchers at Brigham & Women's Hospital on predicting adverse drug events and hospital readmissions for patients who have been admitted for congestive heart failure.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.